YY1 and melanoma: In this report, it was speculated that YY1 mediated autophagy might provide resistance to BRAF inhibitor vemurafenib, and this notion was supported by the observation that suppression of YY1 sensitizes melanoma cells to vemurafenib both in vitro and in vivo (158).